Home LiteratureArticle Details
PMID: 165675 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Regulation of cyclic GMP levels in the ductus deferens of the rat.

Advances in cyclic nucleotide research ·Vol. 5 ·1975-00-00 ·Pages 339-51

Schultz G, Hardman JG

Abstract

The cyclic GMP level in the ductus deferens is elevated by acetylcholine, norepinephrine, KCl, and the phosphodiesterase inhibitor SC-2964. The presence of extracellular Ca++ is required for the effects of all of these agents on cyclic GMP levels. In addition, Ca++ appears to be an important factor for the basal turnover of cyclic GMP in this tissue, but it may be less important in other tissues. These observations have led us to the following working hypothesis (Fig. 5): The interactions of some hormones or neurotransmitters with membrane receptors secondarily increase cyclic GMP formation after primarily increasing the influx of extracellular Ca++ or changing the distribution of Ca++ among intracellular pools or compartments. However, in addition to this possibility, other hormonal effects on particulate and/or soluble guanylate cyclase that do not involve Ca++ mediation must also be considered. Some agents that are known to increase cyclic GMP in tissues have been reported in preliminary communications to activate cell-free preparations of guanylate cyclase (Amer and McKINNEY, 1973; White, Ignarro, and George, 1973), but these reports have not yet been confirmed by other laboratories. Secretin has been reported to stimulate guanylate cyclase activity from several tissues (Thompson, Johnson, Lavis, and Williams, 1974), but the significance of this report is unclear since secretin has not yet been shown to increase cyclic GMP levels in any tissue. Thus, although not convincingly established, some hormones may increase particulate guanylate cyclase activity in a manner similar to that by which hormones increase adenylate cyclase activity. Alternatively, some hormones may increase soluble guanylate cyclase activity with mediating factors other than Ca++ being involved, or hormone-receptor interaction at the plasma membrane could conceivably induce a dislocation and change in effective activity of a reversibly bound, membrane-associated guanylate cyclase. Elucidating which or how many of these possibilities are operative will require thorough study and understanding of the fundamental behavior and properties of soluble and particulate guanylate cyclase activities.

MeSH Terms
Acetylcholine/pharmacology Animals Atropine/pharmacology Calcium/pharmacology Cyclic GMP/metabolism Epinephrine/pharmacology Hormones/pharmacology Male Phentolamine/pharmacology Potassium Chloride/pharmacology Propranolol/pharmacology Rats Time Factors Vas Deferens/drug effects,metabolism Xanthines/pharmacology
Chemicals
Hormones Xanthines Potassium Chloride Atropine Propranolol Cyclic GMP Acetylcholine Calcium Epinephrine Phentolamine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Schultz G
Hardman J G
Article Info
Journal
Advances in cyclic nucleotide research
Abbr.
Adv Cyclic Nucleotide Res
ISSN
0084-5930
Published
1975-00-00
Pages
339-51
Language
English
Region
United States
NLM ID
0341362
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com